Sagent Pharmaceuticals Announces Launch of Irinotecan Hydrochloride Injection in Single Dose Vials - Yahoo Finance

SCHAUMBURG, Ill., May 17, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT - News) today announced the launch of Irinotecan Injection, the generic form of the chemotherapy drug Camptosar(R), in two latex free, preservative free ...

Prodigy Generics launches injectable irinotecan - News-Medical.Net

Prodigy Generics, a division of Prodigy Health Supplier Corporation (PHS), has launched injectable irinotecan. Irinotecan is the generic equivalent of the branded drug Camptosar by Pfizer. Prodigy partnered with eVenus Pharmaceutical ...

Sagent Launches Irinotecan Hydrochloride Injection In Single Dose Vials - RTT News

(RTTNews) - Sagent Pharmaceuticals Inc. (SGNT: News ) announced the launch of Irinotecan Injection, the generic form of the chemotherapy drug Camptosar, in two latex free, preservative free single dose vials. According to IMS data for the twelve-months ...

Irinotecan HCl Injection from Sagent - Monthly Prescribing Reference

Sagent has launched Irinotecan Injection, the generic form of the chemotherapy drug Camptosar, in two latex-free, preservative-free single dose vials. The product is available in 40mg/2mL and 100mg/5mL single-dose vials. Irinotecan HCl injection is an ...

Alchemia Limited : Open Briefing - 4-traders (press release)

Alchemia Limited (ACL) yesterday announced that the independent Data Safety Monitoring Board (DSMB) for the Phase III clinical trial of its lead cancer drug, HA-Irinotecan, in second or third line metastatic colorectal cancer, has approved the continuation ...

Oppenheimer Starts Merrimack Pharmaceuticals (MACK) at Outperform, $12 Target - StreetInsider.com

MM-398, a liposomal irinotecan, has shown strong ph.II pancreatic cancer results, and we see a good probability of ph.III success, mid-'13. Additionally, MACK's earlier antibody-based candidates, MM-111/MM-302/MM-151, address blockbuster markets.

New cancer drugs held up by the NHS for nine years as rationing body accused of letting down patients - Daily Mail

The average delay for multiple drugs given the green light in 2005 was 8.7 years. They included treatments for bowel cancer (irinotecan and oxaliplatin) and cancer of the womb (topotecan and pacilitaxel). In 2006 NICE approved three Alzheimer’s drugs ...

Enzon and Hisun Announce Strategic Alliance for Enzon's Customized PEGylation Linker Technology and Licensing Agreement for PEG-SN38 in China - msnbc.com

It is a PEGylated conjugate of SN38, the active metabolite of the widely used anti-cancer drug irinotecan. PEG-SN38 offers therapeutic advantages over unmodified SN38, including increased solubility, higher exposure and tumor accumulation ...

Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - msnbc.com

Irinotecan (Campotsar), Ixabepilone (Ixempra), KW 2450, Lapatinib (Tykerb), Letrozole (Femara), Leuprorelin depot (Carcinil), Litronesib, Lobaplatin, MEDI 573, MetMAb, Mitoxantrone (Novantrone), Motesanib, MVA-BN-HER2 AutoVac, N-Acetyl GM3 ...

Major Milestone Reached in Salient Pharmaceuticals' Phase II Trial - Houston Chronicle

Launched in February 2009, the Phase II trial is studying the ability of Salient’s product to prevent and/or treat diarrhea in metastatic colorectal cancer patients receiving irinotecan®. It is being supported by the National Cancer Institute’s ...